{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:28:59Z","timestamp":1792121339529,"version":"4.4.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T00:00:00Z","timestamp":1236124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s10875-009-9279-7","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T14:07:42Z","timestamp":1236089262000},"page":"532-544","source":"Crossref","is-referenced-by-count":17,"title":["CD3\u03b6 Expression and T Cell Proliferation are Inhibited by TGF-\u03b21 and IL-10 in Cervical Cancer Patients"],"prefix":"10.1007","volume":"29","author":[{"given":"Cinthya E.","family":"D\u00edaz-Ben\u00edtez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla R.","family":"Navarro-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Flores-Sosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Ju\u00e1rez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe J.","family":"Uribe-Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Rom\u00e1n-Basaure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig E.","family":"Gonz\u00e1lez-Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Alonso de Ru\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermina","family":"L\u00f3pez-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Lagunas-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor H.","family":"Berm\u00fadez-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Alcocer-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Mart\u00ednez-Barnetche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio","family":"Hern\u00e1ndez-Pando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Madrid-Marina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,4]]},"reference":[{"key":"9279_CR1","first-page":"619","volume":"3","author":"MF Mitchell","year":"1994","unstructured":"Mitchell MF, Hittelman WN, Hong WK, Lotan R, Schottenfeld D. The natural history of cervical intraepithelial neoplasia: an argument for intermediate endpoint biomarkers. Cancer Epidemiol Biomarkers Prev. 1994;3:619\u201326.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"9279_CR2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJ, Mu\u00f1oz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12\u20139. doi: 10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F .","journal-title":"J Pathol."},{"key":"9279_CR3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ijc.2910460210","volume":"46","author":"M Melbye","year":"1990","unstructured":"Melbye M, Palefsky J, Gonzales J, Ryder LP, Nielsen H, Bergmann O, Pindborg J, Biggar RJ. Immune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalities. Int J Cancer. 1990;46:203\u20136. doi: 10.1002\/ijc.2910460210 .","journal-title":"Int J Cancer."},{"key":"9279_CR4","first-page":"79","volume":"12","author":"G Gentile","year":"1991","unstructured":"Gentile G, Formelli G, Orsoni G, Rinaldi AM, Busacchi P. Immunosuppression and human genital papillomavirus infection. Eur J Gynaecol Oncol. 1991;12:79\u201381.","journal-title":"Eur J Gynaecol Oncol."},{"key":"9279_CR5","first-page":"609","volume":"61","author":"K Nasiell","year":"1983","unstructured":"Nasiell K, Nasiell M, Va\u0107lavinkov\u00e1 V. Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol. 1983;61:609\u201314.","journal-title":"Obstet Gynecol."},{"key":"9279_CR6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3349\/ymj.1989.30.2.164","volume":"30","author":"TK Park","year":"1989","unstructured":"Park TK, Kim SN. Cell-mediated immunity in patients with invasive carcinoma of the cervix. Yonsei Med J. 1989;30:164\u201372.","journal-title":"Yonsei Med J."},{"key":"9279_CR7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ni969","volume":"4","author":"RA Seder","year":"2003","unstructured":"Seder RA, Ahmed R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol. 2003;4:835\u201342. doi: 10.1038\/ni969 .","journal-title":"Nat Immunol."},{"key":"9279_CR8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","volume":"24","author":"CT Weaver","year":"2006","unstructured":"Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 2006;24:677\u201388. doi: 10.1016\/j.immuni.2006.06.002 .","journal-title":"Immunity."},{"key":"9279_CR9","first-page":"4","volume":"64","author":"J Damoiseaux","year":"2006","unstructured":"Damoiseaux J. Regulatory T cells: back to the future. Neth J Med. 2006;64:4\u20139.","journal-title":"Neth J Med."},{"key":"9279_CR10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00281-006-0019-2","volume":"28","author":"SJ Robertson","year":"2006","unstructured":"Robertson SJ, Hasenkrug KJ. The role of virus-induced regulatory T cells in immunopathology. Springer Semin Immunopathol. 2006;28:51\u201362. doi: 10.1007\/s00281-006-0019-2 .","journal-title":"Springer Semin Immunopathol."},{"key":"9279_CR11","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.4049\/jimmunol.167.5.2972","volume":"167","author":"BC Sheu","year":"2001","unstructured":"Sheu BC, Lin RH, Lien HC, Ho HN, Hsu SM, Huang SC. Predominant Th2\/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol. 2001;167:2972\u20138.","journal-title":"J Immunol."},{"key":"9279_CR12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/vim.2006.19.481","volume":"19","author":"JM Alcocer-Gonz\u00e1lez","year":"2006","unstructured":"Alcocer-Gonz\u00e1lez JM, Berumen J, Tam\u00e9z-Guerra R, Berm\u00fadez-Morales V, Peralta-Zaragoza O, Hern\u00e1ndez-Pando R, Moreno J, Gariglio P, Madrid-Marina V. In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells. Viral Immunol. 2006;19:481\u201391. doi: 10.1089\/vim.2006.19.481 .","journal-title":"Viral Immunol."},{"key":"9279_CR13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9440(10)65149-8","volume":"155","author":"G Bellone","year":"1999","unstructured":"Bellone G, Turletti A, Artusio E, Mareschi K, Carbone A, Tibaudi D, Robecchi A, Emanuelli G, Rodeck U. Tumor-associated transforming growth factor-\u03b2 and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. Am J Pathol. 1999;155:537\u201347.","journal-title":"Am J Pathol."},{"key":"9279_CR14","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.4049\/jimmunol.148.12.3847","volume":"148","author":"TH Inge","year":"1992","unstructured":"Inge TH, McCoy KM, Susskind BM, Barrett SK, Zhao G, Bear HD. Immunomodulatory effects of transforming growth factor-\u03b2 on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes. J Immunol. 1992;148:3847\u201356.","journal-title":"J Immunol."},{"key":"9279_CR15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1084\/jem.166.2.571","volume":"166","author":"T Espevik","year":"1987","unstructured":"Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard HM, Palladino MA. Inhibition of cytokine production by cyclosporin A and transforming growth factor\u03b2. J Exp Med. 1987;166:571\u20136. doi: 10.1084\/jem.166.2.571 .","journal-title":"J Exp Med."},{"key":"9279_CR16","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/1097-0142(19951015)76:8<1411::AID-CNCR2820760817>3.0.CO;2-V","volume":"76","author":"RP Edwards","year":"1995","unstructured":"Edwards RP, Kuykendall K, Crowley-Nowick P, Partridge EE, Shingleton HM, Mestecky J. T lymphocytes infiltrating advanced grades of cervical neoplasia. CD8-positive cells are recruited to invasion. Cancer. 1995;76:1411\u20135. doi: 10.1002\/1097-0142(19951015)76:8<1411::AID-CNCR2820760817>3.0.CO;2-V .","journal-title":"Cancer."},{"key":"9279_CR17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1158\/0008-5472.CAN-06-3388","volume":"67","author":"SJ Piersma","year":"2007","unstructured":"Piersma SJ, Jordanova ES, van Poelgeest MI, Kwappenberg KM, van der Hulst JM, Drijfhout JW, Melief CJ, Kenter GG, Fleuren GJ, Offringa R, van der Burg SH. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res. 2007;67:354\u201361. doi: 10.1158\/0008-5472.CAN-06-3388 .","journal-title":"Cancer Res."},{"key":"9279_CR18","first-page":"329","volume":"5","author":"I Kuss","year":"1999","unstructured":"Kuss I, Saito T, Johnson JT, Whiteside TL. Clinical significance of decreased \u03b6 chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin Cancer Res. 1999;5:329\u201334.","journal-title":"Clin Cancer Res."},{"key":"9279_CR19","first-page":"1825","volume":"2","author":"K Kono","year":"1996","unstructured":"Kono K, Ressing ME, Brandt RM, Melief CJ, Potkul RK, Andersson B, Petersson M, Kast WM, Kiessling R. Decreased expression of signal-transducing \u03b6 chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res. 1996;2:1825\u20138.","journal-title":"Clin Cancer Res."},{"key":"9279_CR20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.bjc.6690179","volume":"79","author":"TD Gruijl de","year":"1999","unstructured":"de Gruijl TD, Bontkes HJ, Peccatori F, Gallee MP, Helmerhorst TJ, Verheijen RH, Aarbiou J, Mulder WM, Walboomers JM, Meijer CJ, van de Vange N, Scheper RJ. Expression of CD3-\u03b6 on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes. Br J Cancer. 1999;79:1127\u201332. doi: 10.1038\/sj.bjc.6690179 .","journal-title":"Br J Cancer."},{"key":"9279_CR21","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0092-8674(91)90310-U","volume":"64","author":"RD Klausner","year":"1991","unstructured":"Klausner RD, Samelson LE. T cell antigen receptor activation pathways: the tyrosine kinase connection. Cell. 1991;64:875\u20138. doi: 10.1016\/0092-8674(91)90310-U .","journal-title":"Cell."},{"key":"9279_CR22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0022-1759(86)90079-7","volume":"90","author":"TL Whiteside","year":"1986","unstructured":"Whiteside TL, Miescher S, MacDonald HR, Von Fliedner V. Separation of tumor-infiltrating lymphocytes from tumor cells in human solid tumors. A comparison between velocity sedimentation and discontinuous density gradients. J Immunol Methods. 1986;90:221\u201333. doi: 10.1016\/0022-1759(86)90079-7 .","journal-title":"J Immunol Methods."},{"key":"9279_CR23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0959-8049(98)00371-2","volume":"35","author":"TD Gruijl de","year":"1999","unstructured":"de Gruijl TD, Bontkes HJ, van den Muysenberg AJ, van Oostveen JW, Stukart MJ, Verheijen RH, van der Vange N, Snijders PJ, Meijer CJ, Wallboomers JM, Scheper RJ. Differences in cytokine mRNA profiles between pre-malignant and malignant lesions of the uterine cervix. Eur J Cancer. 1999;35:490\u20137. doi: 10.1016\/S0959-8049(98)00371-2 .","journal-title":"Eur J Cancer."},{"key":"9279_CR24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1124\/jpet.103.051557","volume":"306","author":"A Ba\u00f1uelos","year":"2003","unstructured":"Ba\u00f1uelos A, Reyes E, Ocadiz R, Alvarez E, Moreno M, Monroy A, Gariglio P. Neocarzinostatin induces an effective p53-dependent response in human papillomavirus-positive cervical cancer cells. J Pharmacol Exp Ther. 2003;306:671\u201380. doi: 10.1124\/jpet.103.051557 .","journal-title":"J Pharmacol Exp Ther."},{"key":"9279_CR25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1006\/gyno.2001.6200","volume":"81","author":"AD Santin","year":"2001","unstructured":"Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Gynecol Oncol. 2001;81:424\u201332. doi: 10.1006\/gyno.2001.6200 .","journal-title":"Gynecol Oncol."},{"key":"9279_CR26","first-page":"119","volume":"65","author":"LA Verduzca-Rodr\u00edguez","year":"1997","unstructured":"Verduzca-Rodr\u00edguez LA, Palet-Guzm\u00e1n JA, Aguirre-Gonz\u00e1lez H, Gonz\u00e1lez-Puebla E. Cervico-uterine cancer and age. Ginecol Obstet Mex. 1997;65:119\u201322.","journal-title":"Ginecol Obstet Mex."},{"key":"9279_CR27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0090-1229(89)90224-9","volume":"50","author":"D Matour","year":"1989","unstructured":"Matour D, Melnicoff M, Kaye D, Murasko DM. The role of T cell phenotypes in decreased lymphoproliferation of the elderly. Clin Immunol Immunopathol. 1989;50:82\u201399. doi: 10.1016\/0090-1229(89)90224-9 .","journal-title":"Clin Immunol Immunopathol."},{"key":"9279_CR28","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1128\/CMR.10.4.742","volume":"10","author":"JH Curfs","year":"1997","unstructured":"Curfs JH, Meis JF, Hoogkamp-korstanje JA. A primer on cytokines: sources, receptors, effects and inducers. Clin Microbiol Rev. 1997;10:742\u201380.","journal-title":"Clin Microbiol Rev."},{"key":"9279_CR29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2003.09.020","volume":"92","author":"A Fattorossi","year":"2004","unstructured":"Fattorossi A, Battaglia A, Ferrandina G, Buzzonetti A, Legge F, Salutari V, Scambia G. Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients. Gynecol Oncol. 2004;92:106\u201315. doi: 10.1016\/j.ygyno.2003.09.020 .","journal-title":"Gynecol Oncol."},{"key":"9279_CR30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/jnci\/89.3.245","volume":"89","author":"M Clerici","year":"1997","unstructured":"Clerici M, Merola M, Ferrario E, Trabattoni D, Villa ML, Stefanon B, Venzon DJ, Shearer GM, De Palo G, Clerici E. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst. 1997;89:245\u201350. doi: 10.1093\/jnci\/89.3.245 .","journal-title":"J Natl Cancer Inst."},{"key":"9279_CR31","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/jcp.2004.025072","volume":"58","author":"AG Bais","year":"2005","unstructured":"Bais AG, Beckmann I, Lindemans J, Ewing PC, Meijer CJ, Snijders PJ, Helmerhorst TJ. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J Clin Pathol. 2005;58:1096\u2013100. doi: 10.1136\/jcp.2004.025072 .","journal-title":"J Clin Pathol."},{"key":"9279_CR32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/A:1014252402630","volume":"22","author":"PE Castle","year":"2002","unstructured":"Castle PE, Hildesheim A, Bowman FP, Strickler HD, Walker JL, Pustilnik T, Edwards RP, Crowley-Nowick PA. Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels. J Clin Immunol. 2002;22:23\u20137. doi: 10.1023\/A:1014252402630 .","journal-title":"J Clin Immunol."},{"key":"9279_CR33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0959-8049(02)00839-0","volume":"39","author":"A Gey","year":"2003","unstructured":"Gey A, Kumari P, Sambandam A, Lecuru F, Cassard L, Badoual C, Fridman C, Nagarajan B, Fridman WH, Tartour E. Identification and characterisation of a group of cervical carcinoma patients with profound downregulation of intratumoral type 1 (IFNgamma) and Type 2 (IL-4) cytokine mRNA expression. Eur J Cancer. 2003;39:595\u2013603. doi: 10.1016\/S0959-8049(02)00839-0 .","journal-title":"Eur J Cancer."},{"key":"9279_CR34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","volume":"389","author":"H Groux","year":"1997","unstructured":"Groux H, O\u2019Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MGA. CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737\u201342. doi: 10.1038\/39614 .","journal-title":"Nature."},{"key":"9279_CR35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00281-006-0019-2","volume":"28","author":"SJ Robertson","year":"2006","unstructured":"Robertson SJ, Hasenkrug KJ. The role of virus-induced regulatory T cells in immunopathology. Springer Semin Immunopathol. 2006;28:51\u201362. doi: 10.1007\/s00281-006-0019-2 .","journal-title":"Springer Semin Immunopathol."},{"key":"9279_CR36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ni1180","volume":"6","author":"H Boehmer von","year":"2005","unstructured":"von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol. 2005;6:338\u201344. doi: 10.1038\/ni1180 .","journal-title":"Nat Immunol."},{"key":"9279_CR37","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","volume":"198","author":"W Chen","year":"2003","unstructured":"Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. Conversion of peripheral CD4+ CD25\u2212 naive T cells to CD4+ CD25+ regulatory T cells by TGF-\u03b2 induction of transcription factor Foxp3. J Exp Med. 2003;198:1875\u201386. doi: 10.1084\/jem.20030152 .","journal-title":"J Exp Med."},{"key":"9279_CR38","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.4049\/jimmunol.166.12.7282","volume":"166","author":"S Yamagiwa","year":"2001","unstructured":"Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA. A role for TGF-\u03b2 in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol. 2001;166:7282\u20139.","journal-title":"J Immunol."},{"key":"9279_CR39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nri1434","volume":"4","author":"M Baniyash","year":"2004","unstructured":"Baniyash M. TCR \u03b6-chain downregulation: curtailing an excessive inflammatory immune response. Nat Rev Immunol. 2004;4:675\u201387. doi: 10.1038\/nri1434 .","journal-title":"Nat Rev Immunol."},{"key":"9279_CR40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00281-006-0035-2","volume":"28","author":"K Tsuzaka","year":"2006","unstructured":"Tsuzaka K, Nozaki K, Kumazawa C, Shiraishi K, Setoyama Y, Yoshimoto K, Abe T, Takeuchi T. TCR\u03b6 mRNA splice variant forms observed in the peripheral blood T cells from systemic lupus erythematosus patients. Springer Semin Immunopathol. 2006;28:185\u201393. doi: 10.1007\/s00281-006-0035-2 .","journal-title":"Springer Semin Immunopathol."},{"key":"9279_CR41","first-page":"1422","volume":"59","author":"BR Gastman","year":"1999","unstructured":"Gastman BR, Johnson DE, Whiteside TL, Rabinowich H. Caspase-mediated degradation of T-cell receptor \u03b6-chain. Cancer Res. 1999;59:1422\u20137.","journal-title":"Cancer Res."},{"key":"9279_CR42","doi-asserted-by":"crossref","first-page":"13119","DOI":"10.1073\/pnas.93.23.13119","volume":"93","author":"M Otsuji","year":"1996","unstructured":"Otsuji M, Kimura Y, Aoe T, Okamoto Y, Saito T. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 \u03b6 chain of T-cell receptor complex and antigen-specific T-cell responses. Proc Natl Acad Sci U S A. 1996;93:13119\u201324. doi: 10.1073\/pnas.93.23.13119 .","journal-title":"Proc Natl Acad Sci U S A."},{"key":"9279_CR43","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","volume":"176","author":"F Fallarino","year":"2006","unstructured":"Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C, Orabona C, Bianchi R, Belladona ML, Volpi C, Santamaria P, Fioretti MC, Puccetti P. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor \u03b6-chain and induce a regulatory phenotype in naive T cells. J Immunol. 2006;176:6752\u201361.","journal-title":"J Immunol."},{"key":"9279_CR44","doi-asserted-by":"crossref","first-page":"21123","DOI":"10.1074\/jbc.M110675200","volume":"277","author":"PC Rodriguez","year":"2002","unstructured":"Rodriguez PC, Zea AH, Culotta KS, Zabaleta J, Ochoa JB, Ochoa AC. Regulation of T cell receptor CD3\u03b6 chain expression by L-arginine. J Biol Chem. 2002;277:21123\u20139. doi: 10.1074\/jbc.M110675200 .","journal-title":"J Biol Chem."},{"key":"9279_CR45","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1349-7006.2007.00470.x","volume":"98","author":"T Nakamura","year":"2007","unstructured":"Nakamura T, Shima T, Saeki A, Hidaka T, Nakashima A, Takikawa O, Saito S. Expression of indoleamine 2,3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Cancer Sci. 2007;98:874\u201381. doi: 10.1111\/j.1349-7006.2007.00470.x .","journal-title":"Cancer Sci."},{"key":"9279_CR46","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1210\/jcem.86.5.7442","volume":"86","author":"KJ Sales","year":"2001","unstructured":"Sales KJ, Katz AA, Davis M, Hinz S, Soeters RP, Hofmeyr MD, Millar RP, Jabbour HN. Cyclooxygenase-2 expression and prostaglandin E2 synthesis are up-regulated in carcinomas of the cervix: a possible autocrine\/paracrine regulation of neoplastic cell function via EP2\/EP4 receptors. J Clin Endocrinol Metab. 2001;86:2243\u20139. doi: 10.1210\/jc.86.5.2243 .","journal-title":"J Clin Endocrinol Metab."},{"key":"9279_CR47","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1158\/0008-5472.CAN-05-0141","volume":"65","author":"S Sharma","year":"2005","unstructured":"Sharma S, Yang SC, Zhu L, Reckamp K, Gardner B, Baratelli F, Huang M, Batra RK, Dubinett SM. Tumor cyclooxygenase-2\/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer. Cancer Res. 2005;65:5211\u201320. doi: 10.1158\/0008-5472.CAN-05-0141 .","journal-title":"Cancer Res."},{"key":"9279_CR48","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1158\/0008-5472.CAN-06-4273","volume":"67","author":"K Subbaramaiah","year":"2007","unstructured":"Subbaramaiah K, Dannenberg AJ. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor\/coactivator exchange. Cancer Res. 2007;67:3976\u201385. doi: 10.1158\/0008-5472.CAN-06-4273 .","journal-title":"Cancer Res."},{"key":"9279_CR49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1006\/cyto.2001.0909","volume":"14","author":"MY Tjiong","year":"2001","unstructured":"Tjiong MY, van der Vange N, ter Schegget JS, Burger MPM, ten Kate FWJ, Out TA. Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia. Cytokine. 2001;14:357\u201360. doi: 10.1006\/cyto.2001.0909 .","journal-title":"Cytokine."},{"key":"9279_CR50","first-page":"925s","volume":"7","author":"W Bernstorff von","year":"2001","unstructured":"von Bernstorff W, Voss M, Freichel S, Schmid A, Vogel I, J\u00f6hnk C, Henne-Bruns D, Kremer B, Kalthoff H. Systemic and local immunosuppression in pancreatic cancer patients. Clin Cancer Res. 2001;7:925s\u201332s.","journal-title":"Clin Cancer Res."},{"key":"9279_CR51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00000658-199508000-00007","volume":"222","author":"FM Kong","year":"1995","unstructured":"Kong FM, Anscher MS, Murase T, Abbott BD, Iglehart JD, Jirtle RL. Elevated plasma transforming growth factor-\u03b21 levels in breast cancer patients decrease after surgical removal of the tumor. Ann Surg. 1995;222:155\u201362. doi: 10.1097\/00000658-199508000-00007 .","journal-title":"Ann Surg."},{"key":"9279_CR52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00008390-199502000-00008","volume":"5","author":"W Dummer","year":"1995","unstructured":"Dummer W, Becker JC, Schwaaf A, Leverkus M, Moll T, Br\u00f6cker EB. Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma. Melanoma Res. 1995;5:67\u20138. doi: 10.1097\/00008390-199502000-00008 .","journal-title":"Melanoma Res."},{"key":"9279_CR53","first-page":"865","volume":"53","author":"TL Whiteside","year":"2004","unstructured":"Whiteside TL. Down-regulation of \u03b6-chain expression in T cell: a biomarker of prognosis in cancer? Cancer Immunol Immunother. 2004;53:865\u201378.","journal-title":"Cancer Immunol Immunother."},{"key":"9279_CR54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0166-3542(02)00070-0","volume":"55","author":"I Arany","year":"2002","unstructured":"Arany I, Grattendick KG, Tyring SK. Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5\u2032-segment of the upstream regulatory region (URR). Antiviral Res. 2002;55:331\u20139. doi: 10.1016\/S0166-3542(02)00070-0 .","journal-title":"Antiviral Res."},{"key":"9279_CR55","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/vim.2006.19.468","volume":"19","author":"O Peralta-Zaragoza","year":"2006","unstructured":"Peralta-Zaragoza O, Bermudez-Morales V, Gutierrez-Xicotencatl L, Alcocer-Gonzalez J, Recillas-Targa F, Madrid-Marina V. E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor \u03b21 promoter throughout Sp1 recognition sequence. Viral Immunol. 2006;19:468\u201380. doi: 10.1089\/vim.2006.19.468 .","journal-title":"Viral Immunol."},{"key":"9279_CR56","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/jnci\/89.17.1285","volume":"89","author":"AS Kadish","year":"1997","unstructured":"Kadish AS, Ho GY, Burk RD, Wang Y, Romney SL, Ledwidge R, Angeletti RH. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia. J Natl Cancer Inst. 1997;89:1285\u201393. doi: 10.1093\/jnci\/89.17.1285 .","journal-title":"J Natl Cancer Inst."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-009-9279-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-009-9279-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-009-9279-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T06:49:10Z","timestamp":1684910950000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-009-9279-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["9279"],"URL":"https:\/\/doi.org\/10.1007\/s10875-009-9279-7","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,4]]}}}